Prothena Corporation plc (NASDAQ: PRTA) on Friday, soared 4.65% from the previous trading day, before settling in for the closing price of $7.10. Within the past 52 weeks, PRTA’s price has moved between $7.01 and $25.42.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 4692.68% annually for the last half of the decade. The company achieved an average annual earnings per share of -54.48%. With a float of $47.13 million, this company’s outstanding shares have now reached $53.83 million.
In an organization with 163 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 56.12%, operating margin of -114.36%, and the pretax margin is -95.39%.
Prothena Corporation plc (PRTA) Insider and Institutional Ownership
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Prothena Corporation plc is 12.44%, while institutional ownership is 85.80%. The most recent insider transaction that took place on May 02 ’25, was worth 27,744,929. In this transaction 10% Owner of this company sold 3,317,938 shares at a rate of $8.36, taking the stock ownership to the 8,266,342 shares. Before that another transaction happened on May 06 ’25, when Company’s 10% Owner sold 1,984,053 for $7.64, making the entire transaction worth $15,164,712. This insider now owns 5,304,596 shares in total.
Prothena Corporation plc (PRTA) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around -54.48% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -9.83% during the next five years compared to -3.15% drop over the previous five years of trading.
Prothena Corporation plc (NASDAQ: PRTA) Trading Performance Indicators
Prothena Corporation plc (PRTA) is currently performing well based on its current performance indicators. A quick ratio of 9.00 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.90.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.08, a number that is poised to hit -0.99 in the next quarter and is forecasted to reach -3.58 in one year’s time.
Technical Analysis of Prothena Corporation plc (PRTA)
Let’s dig in a bit further. During the last 5-days, its volume was 2.51 million. That was better than the volume of 0.66 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 8.52%. Additionally, its Average True Range was 0.76.
During the past 100 days, Prothena Corporation plc’s (PRTA) raw stochastic average was set at 4.75%, which indicates a significant decrease from 16.19% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 55.63% in the past 14 days, which was lower than the 82.58% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $11.40, while its 200-day Moving Average is $15.73. However, in the short run, Prothena Corporation plc’s stock first resistance to watch stands at $8.03. Second resistance stands at $8.64. The third major resistance level sits at $9.19. If the price goes on to break the first support level at $6.87, it is likely to go to the next support level at $6.32. The third support level lies at $5.71 if the price breaches the second support level.
Prothena Corporation plc (NASDAQ: PRTA) Key Stats
Market capitalization of the company is 399.96 million based on 53,827K outstanding shares. Right now, sales total 135,160 K and income totals -122,310 K. The company made 2,120 K in profit during its latest quarter, and -57,960 K in sales during its previous quarter.
